Product name:Vargatef
CAS:928326-83-4
Molecular Formula:C31H33N5O4
Description:Vargatef is a novel angiokinase inhibitor that blocks VEGF, PDGR and FGF receptors. The current phase II study in patients with non small cell lung cancer shows that this oral agent can be given safely. It is far too early to draw conclusions regarding efficacy.